Bolt Biotherapeutics (FRA:6LP) Current Accrued Expense : €6.45 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Bolt Biotherapeutics Current Accrued Expense?

Bolt Biotherapeutics's Current Accrued Expense for the quarter that ended in Mar. 2024 was €6.45 Mil.

Bolt Biotherapeutics's quarterly Current Accrued Expense increased from Sep. 2023 (€5.21 Mil) to Dec. 2023 (€6.11 Mil) and increased from Dec. 2023 (€6.11 Mil) to Mar. 2024 (€6.45 Mil).

Bolt Biotherapeutics's annual Current Accrued Expense increased from Dec. 2021 (€6.64 Mil) to Dec. 2022 (€9.76 Mil) but then declined from Dec. 2022 (€9.76 Mil) to Dec. 2023 (€6.11 Mil).

Bolt Biotherapeutics Current Accrued Expense Historical Data

The historical data trend for Bolt Biotherapeutics's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bolt Biotherapeutics Current Accrued Expense Chart

Bolt Biotherapeutics Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

Get a 7-Day Free Trial

1.27

3.11

6.64

9.76

6.11

Bolt Biotherapeutics Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Current Accrued Expense	Get a 7-Day Free Trial															7.46	5.85	5.21	6.11	6.45

Bolt Biotherapeutics Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Bolt Biotherapeutics Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Bolt Biotherapeutics's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Bolt Biotherapeutics (FRA:6LP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bolt Biotherapeutics Inc (FRA:6LP) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

BOLT:USA 6LP:Germany

Address

900 Chesapeake Drive, Redwood, CA, USA, 94063

Website

https://www.boltbio.com

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems.

Bolt Biotherapeutics (FRA:6LP) Headlines

No Headlines